Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a urine sodium-driven strategy to adjust diuretic therapy in acute decompensated heart failure; study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lakeland Regional Health Systems, Inc. | Conditions: Heart Failure, Heart Failure - NYHA II - IV | Phase 4 | Status: RECRUITING